A flexible membrane based Surface-Enhanced Raman Spectroscopy (SERS) sensor was developed as a viable point-of-care platform to monitor changes of these surrogate indicators of healing status in chronic wounds, such as tumor necrosis factor alpha (TNFα) and matrix metalloproteinase (MMPs). In terms of performance, SERS approach is superior to enzyme-based assays, which are resource intensive. We demonstrated the efficiency of this flexible SERS platform for the sensitive detection of TNFα and MMP9 in the nM to pM range. These substrates may be incorporated into wound dressings to permit routine monitoring of wound status.
We report a label-free Surface Enhanced Raman Spectroscopy (SERS) for pleural fluid analysis to distinguish Lung cancer from controls patients. Herein, we have used a novel silver coated silicon Nanopillar (SCSNP) as SERS substrate to acquire multiple SERS spectra for each pleural fluid sample and advanced chemometrics methods. We report a classification accuracy of 85% along with sensitivity and specificity of 87% and 83% respectively for the detection of Lung cancer over control pleural fluid samples with a receiver operating characteristics (ROC) area under curve value of 0.92 using PLS-DA binary classifier to distinguish between lung cancer over control subjects.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.